Au E, et al. Cancer in kidney transplant recipients. Nat Rev Nephrol 2018; 14:508–520. doi: 10.1038/s41581-018-0022-6

• PubMed
Au E, Cancer in kidney transplant recipients. Nat Rev Nephrol 2018; 14:508–520. doi: 10.1038/s41581-018-0022-6 )| false
• Search Google Scholar
• Export Citation

Howell M, et al. Eliciting patient preferences, priorities and trade-offs for outcomes following kidney transplantation: A pilot best-worst scaling survey. BMJ Open 2016; 6:e008163. doi: 10.1136/bmjopen-2015-008163

• PubMed
Howell M, Eliciting patient preferences, priorities and trade-offs for outcomes following kidney transplantation: A pilot best-worst scaling survey. BMJ Open 2016; 6:e008163. doi: 10.1136/bmjopen-2015-008163 )| false
• Search Google Scholar
• Export Citation

Lipson EJ, et al. Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma. J Clin Oncol 2014;32:e69-e71. doi: 10.1200/JCO.2013.49.2314

• PubMed
Lipson EJ, Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma. J Clin Oncol 2014;32:e69-e71. doi: 10.1200/JCO.2013.49.2314 )| false
• Search Google Scholar
• Export Citation

Lipson EJ, et al. Tumor regression and allograft rejection after administration of anti-PD-1. N Engl J Med 2016; 374:896–898. doi: 10.1056/NEJMc1509268

• PubMed
Lipson EJ, Tumor regression and allograft rejection after administration of anti-PD-1. N Engl J Med 2016; 374:896–898. doi: 10.1056/NEJMc1509268 )| false
• Search Google Scholar
• Export Citation

Murakami N, et al. A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. Kidney Int [published online ahead of print December 23, 2020]. doi: 10.1016/j.kint.2020.12.015; https://www.kidney-international.org/article/S0085-2538(20)31534-9/fulltext

• PubMed
Murakami N, A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. Kidney Int [published online ahead of print December 23, 2020]. doi: 10.1016/j.kint.2020.12.015; https://www.kidney-international.org/article/S0085-2538(20)31534-9/fulltext )| false
• Search Google Scholar
• Export Citation

Abdel-Wahab N, et al. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: An institutional experience and a systematic review of the literature. J Immunother Cancer 2019; 7:106. doi: 10.1186/s40425-019-0585-1

• PubMed
Abdel-Wahab N, Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: An institutional experience and a systematic review of the literature. J Immunother Cancer 2019; 7:106. doi: 10.1186/s40425-019-0585-1 )| false
• Search Google Scholar
• Export Citation

Haslam A, Prasad V. Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw Open 2019; 2:e192535. doi: 10.1001/jamanetworkopen.2019.2535

• PubMed
Haslam A, Prasad V. Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw Open 2019; 2:e192535. doi: 10.1001/jamanetworkopen.2019.2535 )| false
• Search Google Scholar
• Export Citation

Krishnamoorthy S, et al. CAR-T therapy in solid organ transplant recipients with treatment refractory posttransplant lymphoproliferative disorder. Am J Transplant 2021; 21:809–814. doi: 10.1111/ajt.16367

• PubMed
Krishnamoorthy S, CAR-T therapy in solid organ transplant recipients with treatment refractory posttransplant lymphoproliferative disorder. Am J Transplant 2021; 21:809–814. doi: 10.1111/ajt.16367 )| false
• Search Google Scholar
• Export Citation

Mamlouk O, et al. Safety and efficacy of CAR T-cell therapy in kidney transplant recipients. Blood [published online ahead of print December 17, 2020]. doi: 10.1182/blood.2020008759; https://ashpublications.org/blood/article/doi/10.1182/blood.2020008759/474741/Safety-and-Efficacyof-CAR-T-Cell-Therapy-in

• PubMed
Mamlouk O, Safety and efficacy of CAR T-cell therapy in kidney transplant recipients. Blood [published online ahead of print December 17, 2020]. doi: 10.1182/blood.2020008759; https://ashpublications.org/blood/article/doi/10.1182/blood.2020008759/474741/Safety-and-Efficacyof-CAR-T-Cell-Therapy-in )| false
• Search Google Scholar
• Export Citation